Synapse Open Synapse
Biology

Forbion, a prominent biotech investor, raises $2.6B for a pair of venture funds

BioPharma Dive · · 2 min read

The fundraise is the firm’s largest to date, providing a lift for a European biotech industry that’s fallen further behind its counterparts in the U.S. and China.

Latest from BioPharma Dive